Table 3.
Further characteristics of the endometriosis group
| Diagnostic delay (years), mean±1 SD | 8.1±6.5 | |
| Disease duration (years), mean±1 SD | 6.6±5.0 | |
| Diagnosis confirmed by surgery | 100% | |
| Organ affected* (N=148) | ||
| Only peritoneum, n (%) | 10 | (6.8%) |
| Ovaries, n (%) | 98 | (66.2%) |
| Bladder, n (%) | 36 | (24.3%) |
| Vagina, n (%) | 28 | (18.9%) |
| Bowels, n (%) | 54 | (36.5%) |
| Previous treatment† (N=146) | ||
| Analgesic, n (%) | 17 | (11.6%) |
| Hormonal, n (%) | 85 | (58.2%) |
| Surgical, n (%) | 122 | (83.6%) |
| Present treatment† (N=138) | ||
| No treatment, n (%) | 45 | (32.6%) |
| Receiving treatment, n (%) | 93 | (67.4%) |
| Analgesic, n (%) | 28 | (30.1%) |
| Hormonal n (%) | 73 | (78.5%) |
| Awaiting surgery, n (%) | 4 | (2.9%) |
*Multiple choice question.
†Open question inviting free description.